HK1247129A1
(en )
2018-09-21
Combination therapy for the treatment of cancer
IL267795A
(en )
2019-09-26
Combination therapy for the treatment of cancer
HK1251475A1
(en )
2019-02-01
Combination therapy for the treatment of cancer
GB201804255D0
(en )
2018-05-02
Macrophage-based therapy
ZA202206743B
(en )
2023-05-31
Therapy for the treatment of cancer
IL283948A
(en )
2021-07-29
Methods for the treatment of depression
IL280337A
(en )
2021-03-01
Lag-3 combination therapy for the treatment of cancer
IL281845A
(en )
2021-05-31
Combination therapy for the treatment of cancer
GB201900702D0
(en )
2019-03-06
Therapy
GB201819853D0
(en )
2019-01-23
Therapy
SG11202101819QA
(en )
2021-03-30
Gene therapy for the treatment of galactosemia
IL284162A
(en )
2021-08-31
Combination therapy for the treatment of cancer
ZA201901578B
(en )
2022-04-28
Combinations including abx196 for the treatment of cancer
IL280726A
(en )
2021-03-25
Treatment of b cell malignancies
IL286000A
(en )
2021-10-31
Esketamine for the treatment of depression
IL266993A
(en )
2019-07-31
Combination therapy for the treatment of cancer
IL281997A
(en )
2021-05-31
Combination therapy for the treatment of uveal melanoma
SG11202101671PA
(en )
2021-03-30
Anti-lmp2 tcr-t cell therapy for the treatment of ebv-associated cancers
SG11202011434SA
(en )
2020-12-30
Methods for the treatment of bladder cancer
HK1245659A1
(en )
2018-08-31
Cell therapy for the treatment of neurodegeneration
HK1245332A1
(en )
2018-08-24
Cell therapy for the treatment of neurodegeneration
HK1246145A1
(en )
2018-09-07
Cell therapy for the treatment of neurodegeneration
IL253642A0
(en )
2017-09-28
Combination therapy for the treatment of cancer
GB201914848D0
(en )
2019-11-27
Therapy
GB201913797D0
(en )
2019-11-06
Therapy